Platelet-rich Plasma Injections for Persistent Medial Knee Pain After Total Knee Arthroplasty
WithdrawnEarly phase 1NCT03225092
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will investigate the potential effects of platelet rich plasma for the treatment of persistent medial knee pain after total knee arthroplasty. All study participants will receive PRP injections and will be followed up to see if any benefit in regards to pain and/or function is achieved.
Study details
- Official title
- Efficacy of Platelet-rich Plasma Injections for the Treatment of Persistent Medial Knee Pain After Total Knee Arthroplasty
- Conditions
- Knee Pain Chronic
- Pes Anserinus Bursitis
- Status-Post Total Knee Arthroplasty
- Interventions
- Biological: Ultrasound-guided platelet rich plasma injection
- Sponsor
- Ohio State University
- Start date
- 2017-07-18
- Primary completion
- 2018-07-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Person has had a total knee arthroplasty (total knee replacement) 2. Has experienced persistent medial knee pain beyond six months after surgery 3. Has the presumed diagnosis of pes anserine bursitis 4. No pain relief with conventional treatments such as arch supports (if one is flatfooted), NSAID's, and at least two local steroid injections Exclusion Criteria: 1. Person has had a prior knee surgical procedure other than the total knee arthroplasty or an arthroscopic debridement procedure 2. Evidence of knee instability, prosthetic loosening, knee infection, radiculopathy, or hip or back pain 3. Personal history of chronic narcotic or recreational drug use, smoking, psychiatric disorders, or a total hip arthroplasty on the same side of the knee arthroplasty 4. Body mass index (BMI) of greater than 35
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03225092